Bank of America
UTHR icon

Bank of America’s United Therapeutics UTHR Stock Holding History

Bank of America’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,500
Closed -$645K – 7270
2017
Q3 		$645K Buy
+5,500
New +$702K ﹤0.01% 4810
2015
Q2 		– Sell
-30,000
Closed -$5.17M – 7417
2015
Q1 		$5.17M Buy
+30,000
New +$4.57M ﹤0.01% 2464
2014
Q4 		– Sell
-1,500
Closed -$193K – 7984
2014
Q3 		$193K Buy
1,500
+800
+114% +$82.5K ﹤0.01% 5416
2014
Q2 		$62K Sell
700
-700
-50% -$67.3K ﹤0.01% 6495
2014
Q1 		$132K Sell
1,400
-700
-33% -$71.6K ﹤0.01% 5755
2013
Q4 		$237K Sell
2,100
-800
-28% -$72.1K ﹤0.01% 5433
2013
Q3 		$229K Hold
2,900
– – ﹤0.01% 5343
2013
Q2 		$191K Buy
+2,900
New +$187K ﹤0.01% 5662

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bank of America's UTHR Position: Q2 2026 in Review

Bank of America reduced its United Therapeutics (UTHR) stake by 10% in Q2 2026, selling an estimated $11.4M and leaving 179,235 shares worth $97.1M. The position accounts for 0.01% of the portfolio, ranked #1214.

Bank of America first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bank of America held 179,235 shares of United Therapeutics worth $97.1M as of Q2 2026.
  • Bank of America sold 20,191 United Therapeutics shares in Q2 2026, an estimated $11.4M.
  • United Therapeutics made up 0.01% of Bank of America's portfolio in Q2 2026, its #1214 holding.
  • Bank of America first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's United Therapeutics position peaked at $118M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.